Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Keyframe-Entertainment Adds “DMT: The Spirit Molecule” to its Automated Community Film Screening Platform, Keyframe-Cinema
  • USA - English


News provided by

Keyframe-Entertainment

Jul 28, 2014, 04:00 ET

Share this article

Share toX

Share this article

Share toX


The film features mind-blowing visualizations of the DMT experience and motion graphics.

Post this

San Francisco, CA (PRWEB) July 28, 2014 -- Keyframe-Cinema has added “DMT: The Spirit Molecule” to its catalog of Transformational culture films. Created by Keyframe-Entertainment, Keyframe-Cinema is an online service that allows Transformational filmmakers to share their work with fans, film buffs, and festivals. The platform is designed to facilitate the community film screening process, and also automates the licensing and delivery of media to film screeners. Keyframe-Cinema aims to display a variety of Transformational films, including documenting the evolution of Electronic Music Culture by unearthing, gathering and sharing films through community screenings.

Created by Mitch Schultz, “DMT: The Spirit Molecule” is a documentary film that uses Dr. Rick Strassman’s research to investigate dimethyltryptamine (DMT). DMT is an endogenous psychoactive compound, which exists in humans as well as in numerous species of plants and animals. The film condenses over 80 hours of interview footage with cutting-edge computer-generated imagery to capture critical elements of the DMT experience.

The story revolves around Strassman's research, and the experiences of the human test subjects, and draws on a variety of experts to voice unique thoughts and experiences with DMT from within their respective fields. The experts include research scientists, doctors, religious leaders, writers, artists, anthropologists, psychologists, physicists, psychonauts, et al. As Strassman’s story unfolds, these contributors weigh in on his remarkable theories, indigenous use of DMT, the history and future of psychedelics and psychedelic research, and the current news about DMT; including a recent Supreme Court case allowing the use of ayahuasca in the United States within the religious ceremonies of the UDV, a hybrid of indigenousness beliefs with that of Christianity. Other areas of exploration include possible roles for endogenous DMT production, DMT’s role in near-death and birth experiences, alien abduction experiences, and the uncanny likeness to ancient religious texts describing prophets with DMT-like experiences. The contributors offer a comprehensive collection of information, opinions, and speculation to help understand the nature of the DMT experience, and its role in human society and evolution.

To better navigate the expansive realms of Strassman’s DMT universe, popular actor, comedian, and social satirist, Joe Rogan, serves as tour guide. His own personal experiences with DMT, and a fascination that borders on reverence, have motivated him to be a central component of the project. In stylized scenes reminiscent of Rod Sterling’s famous Twilight Zone bookends, Rogan shepherds the audience through the great unknowns of the DMT space.

The film also features guest speakers such as Alex Grey, Eric Davis, Daniel Pinchbeck, as well as footage from Terence McKenna. “DMT: The Spirit Molecule” has met with wide acclaim and recognition, coming in at as the #1 most-streamed documentary on Netflix at time of release and ranking at #3 on the Documentary & Independent lists on iTunes. The film has also gathered a vast network of supporters, consisting of a 3,000,000 direct Partner network reach, over 400,000 Facebook page ‘likes’, as well as over 3,000,000 Youtube views.

That the films featured on Keyframe-Cinema share an ecosystem of supporters is highlighted by communal collaborators involved in related cultural projects. As such, another Transformational film which features Alex Grey, Eric Davis, Daniel Pinchbeck and footage from Terence McKenna is “Electronic Awakening,” also available for screening via Keyframe-Cinema. Produced and Directed by A.C Johner, “Electronic Awakening” investigates the spirituality of Electronic Dance Music culture. Additional film in the catalog includes “AYA: Awakenings,” a narrative documentary that dives into the world and visions of ayahuasca plant medicine and shamanism, adapted from the cult book ‘Aya: a Shamanic Odyssey’ by Rak Razam.

Given the ongoing changes of the film industry, Keyframe-Cinema provides a platform that not only facilitates film screenings but also provides community engagement. As Director Christopher Nolan mentions in an op-ed published by the Wall Street Journal, "The cinema of the future will depend not just on grander presentation, but on the emergence of filmmakers inventive enough to command the focused attention of a crowd for hours." As such, Keyframe-Cinema’s intention of providing the tools to create events that go beyond a typical film experience, for example by having the Director present their work, the Producer Skyping in or having a Q & A panel discussion, enhances the viewing and participation experience.

Keyframe-Cinema encourages filmmakers to tap into their existing fan bases to produce community screenings that viewers can enjoy together and interact thereafter. To learn more and view Keyframe-Cinema’s current film catalog, visit: http://keyframe-cinema.com/films/.

About DMT: The Spirit Molecule
DMT: The Spirit Molecule investigates dimethyltryptamine (DMT), an endogenous psychoactive compound, which exists in humans as well as in numerous species of plants and animals. The feature-length documentary traces Dr. Rick Strassman's government sanctioned human DMT research and its many trials, tribulations, achievements, and inconceivable realizations. This includes looking deeper into the intense psychedelic experience that DMT causes when consumed, and examining DMT’s scientific, spiritual, and cultural relevance. Ultimately, The Spirit Molecule explores the connections between cutting-edge neuroscience, quantum physics, and human spirituality.

About Keyframe-Cinema:
The Keyframe-Cinema film screening platform is an online service that allows Transformational filmmakers to share their work with fans, film buffs, and festivals. The platform is designed to facilitate the community film screening process, and also automates the licensing and delivery of media to film screeners. The creation of the platform was prompted by the combination of industry growth, Keyframe’s love for Electronic Music culture, and its years of experience managing community screening campaigns for “Electronic Awakening” and “The Bloom”. As such, Keyframe-Cinema’s catalog of films aims to display a variety of Transformational films, including documenting the evolution of Electronic Music Culture by unearthing, gathering, and sharing past films through community screenings.

Natacha Pavlov, Keyframe-Entertainment, http://keyframe-entertainment.com/, +1 (415) 573-0856, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.